Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2824
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05297565 | A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection | ||
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | ||
| NCT03831295 | SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies | ||
| NCT03766581 | A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel | ||
| NCT00208169 | Abilify Therapy for Reducing Comorbid Substance Abuse | ||
| NCT01696045 | Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma | ||
| NCT03726281 | Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors | ||
| NCT02546817 | Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS | ||
| NCT00112580 | MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery | ||
| NCT04431635 | Dose De-escalation Study of the PI3k Alpha/Delta Inhibitor, Copanlisib Given in Combination With the Immunotherapeutic Agents, Nivolumab and Rituximab in Patients With Relapsed/Refractory Indolent Lymphoma | ||
| NCT05413018 | An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete Remission | ||
| NCT05080218 | COVID-19 VaccinE Response in Rheumatology Patients | ||
| NCT02812524 | Ipilimumab for Head and Neck Cancer Patients | ||
| NCT01351480 | Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients | ||
| NCT04776395 | Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma | ||
| NCT00050102 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma | ||
| NCT05319093 | Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients | ||
| NCT03340129 | Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) | ||
| NCT00039195 | Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma | ||
| NCT05426239 | Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database | ||
| NCT01002807 | Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State | ||
| NCT00324077 | Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase | ||
| NCT05818592 | Screening for Atrial Fibrillation With Self Pulse Monitoring | ||
| NCT00104130 | Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer | ||
| NCT03575234 | Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer | ||
| NCT03825367 | Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML | ||
| NCT01247766 | Safety Study of Abatacept to Treat Rheumatoid Arthritis | ||
| NCT04570839 | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. | ||
| NCT03634969 | An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants | ||
| NCT02108639 | To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet | ||
| NCT01492374 | Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease | ||
| NCT02208882 | Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120 | ||
| NCT05516537 | Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments. | ||
| NCT00296803 | PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome | ||
| NCT00002369 | A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs | ||
| NCT02873962 | A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib | ||
| NCT00251498 | Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT03219671 | Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS) | ||
| NCT07077434 | A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors | ||
| NCT02717364 | Yervoy® Postmarketing Surveillance for Patients in Japan With Unresectable, Malignant Melanoma | ||
| NCT03241264 | A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body | ||
| NCT06452329 | A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer | ||
| NCT02697851 | Pharmacokinetic Effect of Evotaz/Microgynon Co-administration | ||
| NCT03276429 | Lung Cancer Registry for Lung Cancer Patients | ||
| NCT00248287 | PhII ICb With/Without Erbitux in MBC Pts | ||
| NCT04328298 | French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T) | ||
| NCT03890809 | An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage | ||
| NCT03807765 | Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases | ||
| NCT03502330 | APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma | ||
| NCT03529890 | Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder |
